Diabetic neuropathy (both peripheral and autonomic neuropathy), diabetic retinopathy.
Adults : 50mg three times a day orally before each meal for the minimum of 12 weeks.
Renal and hepatic impairment.
Monitor renal and hepatic functions during therapy. Warn the patient that yellow-brown or red urine discolorations is due to epalrestat without any harmful effect. Avoid Breast feeding. Use with caution in Pregnancy.
Elevations in liver enzyme levels, hepatitis, nausea, vomiting thrombocytopenia, elevations of blood urea nitrogen and Creatinine concentrations.
|Brand Name||Manufactured by|
|ALDONIL||CADILA PHARMACEUTICALS LTD.|
|ALDONIL OD||CADILA PHARMACEUTICALS LTD.|
|ALDORACE||Sun Pharmaceutical Industries Ltd.|
|EPAREL||MICRO LABS LIMITED|
|RESTAT||GROWNBURY PHARMACEUTI-CALS PVT. LTD|